PAR 8.33% 26.0¢ paradigm biopharmaceuticals limited..

Hi BabbaThere is a difference between the FDA and EMA (TGA is...

  1. 2,829 Posts.
    lightbulb Created with Sketch. 714
    Hi Babba

    There is a difference between the FDA and EMA (TGA is harmonized most closely to the EMA) in terms of approval process. They do however share information when appropriate and there is increasing harmonization where it is structurally similar.

    https://pharmanewsintel.com/features/regulating-and-authorizing-medicines-a-comparison-of-the-fda-and-ema
    https://www.sciencedirect.com/science/article/pii/S2452302X16300638

    Some device and drug companies will have a split strategy and apply in the EU or Aus and then use data from approved products to apply to the FDA.
    PAR has gone for a multicentre approach and is Targeting USA as a key first market. This does risk any failure being in multiple jurisdictions. It is also more cash draining.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.020(8.33%)
Mkt cap ! $90.94M
Open High Low Value Volume
24.5¢ 26.0¢ 24.5¢ $195.9K 781.9K

Buyers (Bids)

No. Vol. Price($)
2 38000 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 102892 9
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.